Atlas One · Host Biology · Scale 07 — System

Hemophilia A

Hemophilia A is X-linked FVIII deficiency (F8 gene; Xq28); severe <1 IU/dL → joint/muscle hemorrhage. Emicizumab (bispecific FIXa/FX mAb; HAVEN-3: ABR 0.3 vs 22.9; FDA 2017) replaced prophylactic FVIII as standard of care in inhibitor and non-inhibitor severe HA.

Also known as: hemophilia A, HA, factor VIII deficiency, FVIII deficiency, hemophilia A with inhibitors, haemophilia A, congenital FVIII deficiency

Scale 07 — SystemScale
draftStatus
2026-06-07Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
hemophilia-a

Hemophilia A

Hemophilia A is X-linked FVIII deficiency (F8 gene; Xq28); severe <1 IU/dL → joint/muscle hemorrhage. Emicizumab (bispecific FIXa/FX mAb; HAVEN-3: ABR 0.3 vs 22.9; FDA 2017) replaced prophylactic FVIII as standard of care in inhibitor and non-inhibitor severe HA.